Clopidogrel: The outcome in the Netherlands

In the previous topic we learned that Sanofi filed a claim for direct infringement against Sandoz in the Netherlands. Below, we will discuss the decision reached by the Dutch court, and its implications. In the next topic we will address the outcome in Belgium.